How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that ...

Celebrus Technologies has transferred 5,463 ordinary shares from treasury following the exercise of employee share options, a routine capital management move that slightly reduces its treasury ...

Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions ...

Celebrus Technologies (LON:CLBS) has had a rough three months with its share price down 21%. However, stock prices ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Celebrus Technologies ( (GB:CLBS)) has ...

Investors in Caladrius Biosciences, Inc. CLBS need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 21, 2022 $2.00 Put had some of the highest ...

*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces the ...

Celebrus Technologies' (LON:CLBS) stock is up by a considerable 22% over the past month. Given the company's impressive performance, we decided to study its financial indicators more closely as a ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the merger of Caladrius Biosciences, Inc. (NASDAQ: CLBS) and Cend Therapeutics, Inc. is fair to ...

Caladrius Biosciences stock was last seen 10.3% higher at $5.55, after the company said it bought the exclusive license to Shire's (SHPG) cell therapy program to treat refractory angina. CLBS shares ...